{"nct_id":"NCT04474470","title":"A Study to Evaluate NT219 Alone and in Combination with ERBITUX® (Cetuximab) in Adults with Advanced Solid Tumors and Head and Neck Cancer","status":"COMPLETED","status_verified_date":"2024-05","start_date":"2020-09-03","start_date_type":"ACTUAL","primary_completion_date":"2024-05-08","primary_completion_date_type":"ACTUAL","completion_date":"2024-05-08","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["PPBT"]}